vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and GAIA, INC (GAIA). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $25.5M, roughly 1.8× GAIA, INC). GAIA, INC runs the higher net margin — -0.3% vs -19.9%, a 19.6% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 5.8%). GAIA, INC produced more free cash flow last quarter ($76.0K vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 9.4%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Gaia, Inc. is a publicly traded (NASDAQ:GAIA) American media company founded in 1988 by Jirka Rysavy in Louisville, Colorado. It owns and operates Gaia TV, a subscription video on-demand service consisting of original and licensed alternative media documentaries, including those on wellness, spirituality and conspiracy theories.
ABCL vs GAIA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $25.5M |
| Net Profit | $-8.9M | $-75.0K |
| Gross Margin | — | 87.6% |
| Operating Margin | -63.7% | -2.6% |
| Net Margin | -19.9% | -0.3% |
| Revenue YoY | 788.4% | 5.8% |
| Net Profit YoY | 73.9% | 91.7% |
| EPS (diluted) | $-0.03 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $25.5M | ||
| Q3 25 | $9.0M | $25.0M | ||
| Q2 25 | $17.1M | $24.6M | ||
| Q1 25 | $4.2M | $23.8M | ||
| Q4 24 | $5.0M | $24.1M | ||
| Q3 24 | $6.5M | $22.0M | ||
| Q2 24 | $7.3M | $21.9M | ||
| Q1 24 | $10.0M | $21.3M |
| Q4 25 | $-8.9M | $-75.0K | ||
| Q3 25 | $-57.1M | $-1.2M | ||
| Q2 25 | $-34.7M | $-2.0M | ||
| Q1 25 | $-45.6M | $-1.2M | ||
| Q4 24 | — | $-907.0K | ||
| Q3 24 | $-51.1M | $-1.2M | ||
| Q2 24 | $-36.9M | $-2.2M | ||
| Q1 24 | $-40.6M | $-971.0K |
| Q4 25 | — | 87.6% | ||
| Q3 25 | — | 86.4% | ||
| Q2 25 | — | 86.7% | ||
| Q1 25 | — | 87.7% | ||
| Q4 24 | — | 88.2% | ||
| Q3 24 | — | 86.1% | ||
| Q2 24 | — | 84.5% | ||
| Q1 24 | — | 85.3% |
| Q4 25 | -63.7% | -2.6% | ||
| Q3 25 | -851.8% | -5.0% | ||
| Q2 25 | -290.2% | -8.9% | ||
| Q1 25 | -1479.6% | -4.3% | ||
| Q4 24 | — | -7.1% | ||
| Q3 24 | -1439.4% | -5.3% | ||
| Q2 24 | -1276.2% | -9.1% | ||
| Q1 24 | -551.5% | -4.0% |
| Q4 25 | -19.9% | -0.3% | ||
| Q3 25 | -637.8% | -4.6% | ||
| Q2 25 | -203.3% | -8.3% | ||
| Q1 25 | -1077.2% | -5.1% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | -785.4% | -5.4% | ||
| Q2 24 | -504.3% | -9.9% | ||
| Q1 24 | -408.0% | -4.6% |
| Q4 25 | $-0.03 | $-0.02 | ||
| Q3 25 | $-0.19 | $-0.05 | ||
| Q2 25 | $-0.12 | $-0.07 | ||
| Q1 25 | $-0.15 | $-0.04 | ||
| Q4 24 | — | $-0.03 | ||
| Q3 24 | $-0.17 | $-0.05 | ||
| Q2 24 | $-0.13 | $-0.09 | ||
| Q1 24 | $-0.14 | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $87.9M |
| Total Assets | $1.4B | $154.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $13.5M | ||
| Q3 25 | $83.2M | $14.2M | ||
| Q2 25 | $92.4M | $13.9M | ||
| Q1 25 | $159.3M | $13.1M | ||
| Q4 24 | $156.3M | $5.9M | ||
| Q3 24 | $126.6M | $4.4M | ||
| Q2 24 | $148.3M | $5.5M | ||
| Q1 24 | $123.6M | $8.6M |
| Q4 25 | $966.9M | $87.9M | ||
| Q3 25 | $964.0M | $86.3M | ||
| Q2 25 | $1.0B | $85.7M | ||
| Q1 25 | $1.0B | $87.0M | ||
| Q4 24 | $1.1B | $80.7M | ||
| Q3 24 | $1.1B | $81.2M | ||
| Q2 24 | $1.1B | $82.1M | ||
| Q1 24 | $1.1B | $84.8M |
| Q4 25 | $1.4B | $154.6M | ||
| Q3 25 | $1.4B | $151.1M | ||
| Q2 25 | $1.4B | $147.0M | ||
| Q1 25 | $1.3B | $148.5M | ||
| Q4 24 | $1.4B | $141.2M | ||
| Q3 24 | $1.4B | $139.6M | ||
| Q2 24 | $1.4B | $142.1M | ||
| Q1 24 | $1.5B | $133.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $1.8M |
| Free Cash FlowOCF − Capex | $-44.6M | $76.0K |
| FCF MarginFCF / Revenue | -99.4% | 0.3% |
| Capex IntensityCapex / Revenue | 21.9% | 6.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $-377.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $1.8M | ||
| Q3 25 | $-52.6M | $326.0K | ||
| Q2 25 | $-32.4M | $2.3M | ||
| Q1 25 | $-11.6M | $1.3M | ||
| Q4 24 | $-108.6M | $2.7M | ||
| Q3 24 | $-28.9M | $409.0K | ||
| Q2 24 | $-30.0M | $-2.1M | ||
| Q1 24 | $-41.7M | $5.9M |
| Q4 25 | $-44.6M | $76.0K | ||
| Q3 25 | $-61.5M | $-1.6M | ||
| Q2 25 | $-45.8M | $880.0K | ||
| Q1 25 | $-22.2M | $268.0K | ||
| Q4 24 | $-187.0M | $1.6M | ||
| Q3 24 | $-47.4M | $-952.0K | ||
| Q2 24 | $-50.1M | $-3.5M | ||
| Q1 24 | $-65.8M | $4.9M |
| Q4 25 | -99.4% | 0.3% | ||
| Q3 25 | -687.0% | -6.4% | ||
| Q2 25 | -267.9% | 3.6% | ||
| Q1 25 | -524.0% | 1.1% | ||
| Q4 24 | -3702.8% | 6.5% | ||
| Q3 24 | -728.4% | -4.3% | ||
| Q2 24 | -683.8% | -16.1% | ||
| Q1 24 | -661.5% | 22.8% |
| Q4 25 | 21.9% | 6.6% | ||
| Q3 25 | 99.7% | 7.7% | ||
| Q2 25 | 78.2% | 5.7% | ||
| Q1 25 | 251.1% | 4.3% | ||
| Q4 24 | 1552.7% | 4.6% | ||
| Q3 24 | 284.6% | 6.2% | ||
| Q2 24 | 274.6% | 6.6% | ||
| Q1 24 | 242.5% | 5.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
GAIA
| US | $16.7M | 65% |
| Non Us | $8.8M | 35% |
